Prospective analysis of circulating metabolites and breast cancer in EPIC.

BMC Med · 2019 · PMC6757362 · PMID 31547832

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline significantP value = 0.051so close (0.05 < p ≤ 0.1)

Adjustment for multiple testing using FDR procedure identified similar significant metabolites, while with Bonferroni correction, only C2 remained associated with risk of breast cancer with a borderline significant P value (Bonferroni P value = 0.051) (Table 2 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.